IOF - International Osteoporosis Foundation

Left Navigation
Member Societies List of Member Societies Member News Committee of National Societies How to Join  
Top Navigation Homepage Search Sitemap Contact IOF Members Only

Hungarian Osteoporosis Patients Association

A breakthrough for male osteoporosis patients

Hungary's Department of Social Security has accepted proposals by the HOPA to reimburse 90% of treatment (alendronate) for male osteoporosis patients. Currently, alendronate is the only osteoporosis treatment indicated for osteoporosis in males.


Back to Society News

Homepage | Search | Sitemap | Contact IOF | Members Only

© 2003 International Osteoporosis Foundation:
About IOF | Legal Disclaimer